Streetbeat News

Stock Prices

BMY

Bristol Myers Squibb & Co's Q3 revenues declined 2% Y/Y to $10.966 billion, primarily due to a 41% drop in sales of Revlimid. However, sales of Opdivo and Eliquis rose 11% and 2% respectively. The company's adjusted EPS of $2.00 beat the consensus of $1.76. The company reiterated its FY23 revenue to fall by low single-digit percentages, primarily due to lower-than-expected Revlimid sales. BMY shares are down 4.79% premarket.

Portfolio Pulse from Anusuya Lahiri

October 26, 2023 | 1:28 pm

SDA

SunCar Technology Group Inc. (NASDAQ:SDA) has announced a follow-on offering of $21 million of Class A Ordinary Shares at a price of $8.18 per share. The company will issue a total of 2,567,238 Ordinary Shares to institutional investors. Additionally, the company will issue common warrants for the purchase of up to 3,850,856 Ordinary Shares at an exercise price of $9.00 per share. The net proceeds from this offering will be used for working capital and general corporate purposes. The offering is expected to close on October 30, 2023.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 1:28 pm

MULN

Mullen Automotive Inc. (NASDAQ:MULN) has been granted a request to continue its listing on The Nasdaq Capital Market by the Nasdaq Hearings Panel. The company must demonstrate compliance with Listing Rule 5550(a)(2) by maintaining a closing bid price of $1 per share for 20 consecutive trading sessions on or before Jan. 22, 2024. Additionally, it must comply with Listing Rule 5620(a) by holding an annual shareholder meeting on or before March 8, 2024.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 1:27 pm

CMCSA

Comcast's shares are trading lower following the release of their Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 1:27 pm

AEHR

HE

PSA

RIVN

SLB

TTD

Jim Cramer, on CNBC’s 'Mad Money Lightning Round', gave his views on several stocks. He suggested waiting for Rivian Automotive's second financing before investing, advised waiting until Public Storage drops to $200 before buying, and praised Schlumberger's 'remarkable' quarter. He warned that Aehr Test Systems is expensive and that the market is divorcing from fundamentals. He also suggested buying The Trade Desk, but waiting until it drops further, and dismissed Hawaiian Electric Industries as a speculative play.

Portfolio Pulse from Lisa Levin

October 26, 2023 | 1:26 pm

CMCSA

Comcast Corp reported a Q3 FY23 revenue growth of 0.9% YoY to $30.12 billion, beating the consensus of $29.69 billion. Adjusted EPS of $1.08 beat the consensus of $0.95. However, the company lost 18,000 broadband customers and 490,000 total video customers. The film 'Oppenheimer' grossed over $900 million in the worldwide box office in Q3. Comcast's shares traded lower by 6.43% at $40.01 premarket on the last check Thursday.

Portfolio Pulse from Anusuya Lahiri

October 26, 2023 | 1:23 pm

BETS

Bit Brother Limited (NASDAQ:BETS) has announced a registered direct offering of $5.04 million. The company will sell 14 million Class A ordinary shares, Class B warrants, and Class C warrants at a combined purchase price of $0.36 per share and associated warrants. The gross proceeds are estimated to be $5.04 million before deducting placement agent fees and other expenses. The offering is expected to close on October 30, 2023.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 1:23 pm

HON

Honeywell has reported signs of relief in supply chains for semiconductors and logistics, according to a recent conference call.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 1:22 pm

FFNW

First Financial Northwest (NASDAQ:FFNW) reported Q3 earnings of $0.16 per share, beating the analyst consensus estimate of $0.15 by 6.67%. However, this is a 62.79% decrease from the same period last year. The company's quarterly sales of $9.70 million missed the analyst consensus estimate of $9.93 million by 2.29%, marking a 23.70% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 1:21 pm

SNOA

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) has announced the pricing of its public offering of 8.5 million shares of common stock at $0.20 per share. The gross proceeds are expected to be approximately $1.7 million, before deducting placement agent fees and commissions and estimated offering expenses. The offering is expected to close on October 30, 2023.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 1:21 pm